IDXX
Status-Quo-PlayerIdexx Laboratories
$574.00
+1.95%
as of 13 Apr
Power Core
IDEXX's moat is the vertically integrated loop of proprietary instruments, consumables, reference laboratories, and practice management software that embeds the company into the clinical workflow of veterinary practices with compounding switching costs.
Direction of Movement
Structural Growth Intact Despite Post-Pandemic Visit Normalization
ROC 200
+9.4%
IDXX
Idexx Laboratories
$574.00
+1.95%
as of 13 Apr
DCF Fair Value: $166.24
Market data unavailable
Company Profile
IDEXX Laboratories, Inc. is an American multinational corporation that develops, manufactures, and distributes diagnostic products and services for veterinary and environmental markets. The company specializes in solutions for companion animal health, including in-clinic laboratory analyzers like the Catalyst Dx Chemistry Analyzer and ProCyte Dx Hematology Analyzer, pet-side SNAP tests, diagnostic imaging systems, and veterinary practice management software such as Cornerstone. It also offers water testing products like Colilert for detecting coliforms and E. coli, alongside diagnostics for livestock, poultry, and dairy to monitor diseases in herds and flocks, as well as milk quality. Additionally, IDEXX provides point-of-care and laboratory diagnostics through OPTI Medical Systems for human medicine. These offerings support veterinarians, water utilities, livestock producers, and reference laboratories worldwide, enhancing health monitoring and safety in pet care, agriculture, and public health. Founded in 1983 and headquartered in Westbrook, Maine, IDEXX Laboratories, Inc. plays a key role in advancing diagnostic innovation across these essential sectors.